University of Michigan leads advisory panel to debate on approving new COVID-19 vaccine
This week a University of Michigan expert leads a panel weighing whether to recommend the emergency use of a new vaccine against COVID-19.
The company Johnson and Johnson is seeking emergency authorization for a COVID-19 vaccine that requires only a single dose.
That could make it easier to inoculate large numbers of people, at a time when many state and local officials complain there is not enough vaccine available.
But President Biden told a group at a Pfizer manufacturing plant in Portage last week, that his administration is significantly ramping-up efforts to get vaccine to the public.
“We’re now on track to have enough vaccine supply for all Americans by the end of July. That doesn’t mean it’ll be in all Americans arms, but enough vaccine will be available by that time.”
Johnson and Johnson has a deal with the federal government to provide 100 million doses within four months, but will have only a few million available immediately, if it’s vaccine is approved.